In this webinar, Baha Abdalhamid, MD, PhD, from Nebraska Public Health Laboratory, will speak about his research studies. Baha Abdalhamid’s research uses rapid whole genome sequencing (WGS) and bioinformatics for the in-depth characterization of microorganisms. His research projects use WGS for the diagnosis of foodborne pathogens and sterile body fluid infections. Also, he is using WGS to explore mutations in SARS-CoV-2 genes to be addressed as novel targets for COVID-19 vaccine development.
Join this webinar to learn why next generation sequencing (NGS) is a powerful tool to detect and differentiate COVID-19 outbreaks. The featured speakers will discuss how NGS can solve the shortage of test supplies during the COVID-19 pandemic. Attendees will learn how NGS can be used for COVID-19 diagnosis, monitoring new variants and molecular epidemiology.
Sasan Amini, PhD, CEO of Clear Labs
Sasan Amini combined his academic expertise and passion for healthy living when he co-founded Clear Labs with a mission to set a new paradigm for food safety and quality. Prior to serving as the CEO of Clear Labs, he worked in the Advanced Research department at Illumina. Sasan earned his PhD in Genomics from Princeton and holds multiple patents and publications in the field.Message Presenter
Baha Abdalhamid, MD, PhD, Assistant Professor at the University of Nebraska College of Medicine
The focus of Dr. Abdalhamid’s research is the antimicrobial resistance mechanisms in Gram-negative bacteria. He has conducted investigations to characterize molecular mechanisms of antimicrobial resistance especially in Gram-negative bacteria. With the spread of COVID-19 pandemic, his research studies are also focusing on finding new effective diagnostics methods to conserve testing reagents and expanding SARS-CoV-2 testing such as group testing for pooled specimens in addition to characterization of SARS-CoV-2 genotypes. He did a micromaster program at University of Maryland Global Campus to solidify his background in bioinformatics.
Baha Abdalhamid is an Assistant Professor at the University of Nebraska College of Medicine, Department of Pathology and Microbiology. Baha Abdalhamid has a PhD from the Creighton University School of Medicine in Nebraska.
Who Should Attend?
All professionals focused on molecular epidemiology, SARS-CoV-2 research and detection, including:
- Laboratory directors
- Public health officials
What You Will Learn
Join this webinar to learn:
- Why next generation sequencing (NGS) is a powerful tool to detect and differentiate COVID-19 outbreaks
- How NGS can solve the shortage of test supplies during the COVID-19 pandemic
- How NGS can be used for COVID-19 diagnosis, monitoring new variants and molecular epidemiology
Clear Labs harnesses the power of next-generation sequencing (NGS) to simplify complex diagnostics for clinical and applied markets. By creating a fully automated platform that brings together DNA sequencing, robotics and cloud-based analytics, Clear Labs democratizes genomics applications to deliver increased clarity. Clear Labs’ turnkey platform accelerates outcomes and improves accuracy — from food-borne outbreaks such as listeria and salmonella to infectious diseases, including SARS-CoV-2. With a novel approach, Clear Labs is helping the world better understand, track and mitigate tomorrow’s novel pathogens. For more information, visit https://www.clearlabs.com/.